Magnesium in PDB 5g1z: Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 1)
Enzymatic activity of Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 1)
All present enzymatic activity of Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 1):
2.3.1.97;
Protein crystallography data
The structure of Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 1), PDB code: 5g1z
was solved by
V.Goncalves,
J.A.Brannigan,
A.Laporte,
A.S.Bell,
S.M.Roberts,
A.J.Wilkinson,
R.J.Leatherbarrow,
E.W.Tate,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
59.45 /
1.50
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
57.400,
118.900,
175.300,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
14.9 /
18.7
|
Other elements in 5g1z:
The structure of Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 1) also contains other interesting chemical elements:
Magnesium Binding Sites:
The binding sites of Magnesium atom in the Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 1)
(pdb code 5g1z). This binding sites where shown within
5.0 Angstroms radius around Magnesium atom.
In total 3 binding sites of Magnesium where determined in the
Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 1), PDB code: 5g1z:
Jump to Magnesium binding site number:
1;
2;
3;
Magnesium binding site 1 out
of 3 in 5g1z
Go back to
Magnesium Binding Sites List in 5g1z
Magnesium binding site 1 out
of 3 in the Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 1)
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 1 of Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 1) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Mg1412
b:23.9
occ:1.00
|
O
|
A:LEU169
|
2.8
|
16.4
|
1.0
|
N
|
A:LYS172
|
2.9
|
15.3
|
1.0
|
O1A
|
A:NHW1000
|
3.0
|
13.4
|
1.0
|
O4A
|
A:NHW1000
|
3.0
|
14.0
|
1.0
|
N
|
A:LEU174
|
3.1
|
13.8
|
1.0
|
N
|
A:ARG173
|
3.4
|
13.6
|
1.0
|
CA
|
A:LYS172
|
3.5
|
15.8
|
1.0
|
N
|
A:SER171
|
3.5
|
15.6
|
1.0
|
CB
|
A:LEU174
|
3.5
|
16.0
|
1.0
|
CB
|
A:LYS172
|
3.5
|
16.2
|
1.0
|
C
|
A:LYS172
|
3.6
|
15.2
|
1.0
|
P1A
|
A:NHW1000
|
3.8
|
13.6
|
1.0
|
C
|
A:ARG170
|
3.8
|
15.8
|
1.0
|
CG
|
A:LEU174
|
3.9
|
18.2
|
1.0
|
CA
|
A:LEU174
|
3.9
|
14.3
|
1.0
|
C
|
A:SER171
|
3.9
|
16.4
|
1.0
|
C
|
A:LEU169
|
4.0
|
14.4
|
1.0
|
CA
|
A:ARG170
|
4.0
|
14.4
|
1.0
|
O2A
|
A:NHW1000
|
4.0
|
13.4
|
1.0
|
CD1
|
A:LEU174
|
4.0
|
20.8
|
1.0
|
CG1
|
A:VAL165
|
4.1
|
14.4
|
1.0
|
C
|
A:ARG173
|
4.1
|
15.0
|
1.0
|
P2A
|
A:NHW1000
|
4.2
|
13.9
|
1.0
|
CA
|
A:SER171
|
4.2
|
16.1
|
1.0
|
CA
|
A:ARG173
|
4.2
|
15.4
|
1.0
|
N
|
A:ALA175
|
4.3
|
12.3
|
1.0
|
O3A
|
A:NHW1000
|
4.4
|
13.8
|
1.0
|
N
|
A:ARG170
|
4.4
|
13.8
|
1.0
|
CG
|
A:LYS172
|
4.4
|
19.2
|
1.0
|
O
|
A:LYS172
|
4.4
|
16.6
|
1.0
|
O
|
A:ARG170
|
4.6
|
18.2
|
1.0
|
C
|
A:LEU174
|
4.6
|
13.3
|
1.0
|
O6A
|
A:NHW1000
|
4.7
|
12.9
|
1.0
|
CB
|
A:VAL165
|
4.8
|
11.0
|
1.0
|
CG2
|
A:VAL165
|
4.9
|
14.1
|
1.0
|
|
Magnesium binding site 2 out
of 3 in 5g1z
Go back to
Magnesium Binding Sites List in 5g1z
Magnesium binding site 2 out
of 3 in the Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 1)
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 2 of Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 1) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Mg1412
b:22.6
occ:1.00
|
O
|
B:LEU169
|
2.8
|
16.6
|
1.0
|
N
|
B:LYS172
|
2.9
|
14.3
|
1.0
|
O4A
|
B:NHW1000
|
3.0
|
15.1
|
1.0
|
O1A
|
B:NHW1000
|
3.0
|
14.0
|
1.0
|
N
|
B:LEU174
|
3.2
|
13.3
|
1.0
|
N
|
B:ARG173
|
3.5
|
14.7
|
1.0
|
CA
|
B:LYS172
|
3.5
|
18.3
|
1.0
|
N
|
B:SER171
|
3.5
|
15.9
|
1.0
|
CB
|
B:LEU174
|
3.6
|
15.8
|
1.0
|
CB
|
B:LYS172
|
3.6
|
19.6
|
1.0
|
C
|
B:LYS172
|
3.6
|
16.7
|
1.0
|
P1A
|
B:NHW1000
|
3.8
|
14.6
|
1.0
|
C
|
B:ARG170
|
3.8
|
16.8
|
1.0
|
CA
|
B:LEU174
|
3.9
|
15.2
|
1.0
|
CG
|
B:LEU174
|
3.9
|
19.6
|
1.0
|
C
|
B:LEU169
|
4.0
|
15.6
|
1.0
|
CA
|
B:ARG170
|
4.0
|
15.3
|
1.0
|
C
|
B:SER171
|
4.0
|
18.5
|
1.0
|
O2A
|
B:NHW1000
|
4.0
|
15.5
|
1.0
|
CG1
|
B:VAL165
|
4.0
|
15.8
|
1.0
|
CD1
|
B:LEU174
|
4.1
|
23.5
|
1.0
|
P2A
|
B:NHW1000
|
4.1
|
15.0
|
1.0
|
C
|
B:ARG173
|
4.2
|
14.4
|
1.0
|
CA
|
B:SER171
|
4.2
|
16.4
|
1.0
|
CA
|
B:ARG173
|
4.3
|
15.9
|
1.0
|
N
|
B:ALA175
|
4.3
|
13.1
|
1.0
|
O3A
|
B:NHW1000
|
4.4
|
15.2
|
1.0
|
N
|
B:ARG170
|
4.4
|
16.1
|
1.0
|
O
|
B:LYS172
|
4.4
|
17.2
|
1.0
|
CG
|
B:LYS172
|
4.5
|
22.7
|
1.0
|
O
|
B:ARG170
|
4.6
|
18.7
|
1.0
|
C
|
B:LEU174
|
4.6
|
13.6
|
1.0
|
O6A
|
B:NHW1000
|
4.6
|
14.0
|
1.0
|
CG2
|
B:VAL165
|
4.8
|
13.0
|
1.0
|
CB
|
B:VAL165
|
4.9
|
14.6
|
1.0
|
|
Magnesium binding site 3 out
of 3 in 5g1z
Go back to
Magnesium Binding Sites List in 5g1z
Magnesium binding site 3 out
of 3 in the Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 1)
 Mono view
 Stereo pair view
|
A full contact list of Magnesium with other atoms in the Mg binding
site number 3 of Plasmodium Vivax N-Myristoyltransferase in Complex with A Quinoline Inhibitor (Compound 1) within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:Mg1413
b:21.8
occ:1.00
|
O
|
C:LEU169
|
2.8
|
16.7
|
1.0
|
N
|
C:LYS172
|
2.9
|
16.1
|
1.0
|
O2A
|
C:NHW1000
|
2.9
|
14.9
|
1.0
|
O4A
|
C:NHW1000
|
3.0
|
13.5
|
1.0
|
N
|
C:LEU174
|
3.1
|
13.6
|
1.0
|
N
|
C:ARG173
|
3.4
|
15.1
|
1.0
|
N
|
C:SER171
|
3.4
|
14.9
|
1.0
|
CA
|
C:LYS172
|
3.5
|
16.3
|
1.0
|
CB
|
C:LYS172
|
3.6
|
16.9
|
1.0
|
C
|
C:LYS172
|
3.6
|
16.6
|
1.0
|
CB
|
C:LEU174
|
3.6
|
14.7
|
1.0
|
P1A
|
C:NHW1000
|
3.7
|
13.1
|
1.0
|
C
|
C:ARG170
|
3.8
|
15.5
|
1.0
|
CG
|
C:LEU174
|
3.9
|
17.3
|
1.0
|
CA
|
C:LEU174
|
3.9
|
13.9
|
1.0
|
C
|
C:LEU169
|
3.9
|
13.8
|
1.0
|
O1A
|
C:NHW1000
|
3.9
|
14.2
|
1.0
|
C
|
C:SER171
|
3.9
|
17.3
|
1.0
|
CA
|
C:ARG170
|
3.9
|
14.4
|
1.0
|
CD1
|
C:LEU174
|
4.0
|
19.4
|
1.0
|
CA
|
C:SER171
|
4.1
|
15.5
|
1.0
|
C
|
C:ARG173
|
4.1
|
16.1
|
1.0
|
P2A
|
C:NHW1000
|
4.1
|
14.1
|
1.0
|
CG1
|
C:VAL165
|
4.1
|
13.5
|
1.0
|
CA
|
C:ARG173
|
4.2
|
14.9
|
1.0
|
O3A
|
C:NHW1000
|
4.3
|
14.5
|
1.0
|
CG
|
C:LYS172
|
4.4
|
19.4
|
1.0
|
N
|
C:ALA175
|
4.4
|
11.6
|
1.0
|
N
|
C:ARG170
|
4.4
|
13.8
|
1.0
|
O
|
C:LYS172
|
4.5
|
16.0
|
1.0
|
O
|
C:ARG170
|
4.6
|
18.6
|
1.0
|
C
|
C:LEU174
|
4.6
|
13.3
|
1.0
|
O6A
|
C:NHW1000
|
4.7
|
13.6
|
1.0
|
CG2
|
C:VAL165
|
4.9
|
13.9
|
1.0
|
CB
|
C:VAL165
|
4.9
|
12.3
|
1.0
|
|
Reference:
V.Goncalves,
J.A.Brannigan,
A.Laporte,
A.S.Bell,
S.M.Roberts,
A.J.Wilkinson,
R.J.Leatherbarrow,
E.W.Tate.
Structure-Guided Optimization of Quinoline Inhibitors of Plasmodium N-Myristoyltransferase. Medchemcomm V. 8 191 2017.
ISSN: ISSN 2040-2503
PubMed: 28626547
DOI: 10.1039/C6MD00531D
Page generated: Sun Sep 29 04:34:42 2024
|